Request More Information 

Simoa® Ultra-Sensitive SARS-CoV-2 N Protein RUO Assay

 

For Research Use Only. 

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a recently identified coronavirus strain responsible for the Coronavirus Disease 2019 (COVID-19) and pandemic. The virus infects human cells through interaction between angiotensin-converting enzyme 2 (ACE2) on respiratory cells and spike or S-protein on the outer envelope of the virion particle.

The SARS-CoV-2 Protein Antigen assay is intended for Research Use Only to detect the presence or absence of the nucleocapsid protein antigen from the SARS-CoV-2 virus in nasopharyngeal swab specimens. This nucleocapsid protein (or N protein) is elevated in respiratory fluids during the initial acute phase of the infection. This N protein elevation can be used to measure SARS-CoV-2 infection in its earliest stages, prior to the development of a significant anti-SARS-CoV-2 antibody response.

If you would like to find out more about achieving a higher-sensitivity measure of SARS-Co-V 2 N Protein Antigen in your research, fill out our contact form and someone from our team will get in touch with you.

By submitting the form you agree to Quanterix’s Terms and Conditions. If you have subscribed to our email marketing you can unsubscribe at any time, and you can learn more about how we manage your personal details in our Privacy Policy.